A large international team of researchers has conducted genetic engineering on T cells as a way to combat pancreatic cancer. In their paper published in the journal Nature Biomedical Engineering, the group describes engineering ...
Artificial food colorants can cause disease when the immune system has become dysregulated, Icahn School of Medicine at Mount Sinai researchers report. The study, published in Cell Metabolism in May, was the first to show ...
May 13, 2021
0
408
A team of researchers from multiple countries in Europe and the U.S. has discovered differences in gene expression in children who later develop Type 1 diabetes. In their paper published in the journal Science Translational ...
UConn researcher Paulo Verardi, associate professor of pathobiology and veterinary science in the College of Agriculture, Health and Natural Resources, has demonstrated the success of a vaccine against Zika virus and recently ...
Apr 1, 2021
0
131
The glow of a panther's eyes in the darkness. The zig-zagging of a shark's dorsal fin above the water.
Mar 25, 2021
0
54
Immunologists at St. Jude Children's Research Hospital have discovered that tumors use a unique mechanism to switch on regulatory T cells to protect themselves from attack by the immune system. Surprisingly, the mechanism ...
Feb 24, 2021
0
187
SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists.
Feb 5, 2021
0
88
DNA that ends up where it doesn't belong in cancer cells can unleash an immune response that makes tumors more susceptible to immunotherapy, the results of two UT Southwestern studies indicate. The findings, published online ...
Dec 17, 2020
0
44
Researchers at the University of Pittsburgh School of Medicine have combined synthetic biology with a machine-learning algorithm to create human liver organoids with blood- and bile-handling systems. When implanted into mice ...
Dec 7, 2020
0
115
The Moderna COVID-19 vaccine, which the company says was recently demonstrated to have 94 percent efficacy, causes the human immune system to produce potent antibodies that endure for at least three months, a study showed ...
Dec 3, 2020
0
742
